Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-05 · accession 0000950170-23-046721 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-06 | 2023-09-05 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $1.33 | -3,622 | 798.5K | -0.5% | -$4,817 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | S | D | 64 | $1.32 | 798,396 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-05 | S | D | 3,558 | $1.33 | 798,460 | D | — | — |